Iowa City, IA, United States of America

Melissa Fath


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Melissa Fath

Introduction

Melissa Fath is an accomplished inventor based in Iowa City, IA. She has made significant contributions to the field of cancer treatment, holding three patents that focus on innovative therapeutic methods. Her work aims to improve the efficacy of cancer therapies through novel combinations of active agents.

Latest Patents

Melissa Fath's latest patents include a method of treating cancer that involves administering at least one active agent, such as a thioredoxin reductase inhibitor and a glutathione depleting agent. This method is designed to enhance the effectiveness of cancer treatment. Another notable patent is for a combination cancer therapy that utilizes a pentaaza macrocyclic ring complex along with an ascorbate compound. This approach includes administering an active agent selected from ascorbic acid, its derivatives, or pharmaceutically acceptable salts, in conjunction with the pentaaza macrocyclic ring complex.

Career Highlights

Melissa Fath is currently associated with Galera Labs, LLC, where she continues to develop her innovative ideas in cancer treatment. Her work is characterized by a strong focus on combining different therapeutic agents to create more effective treatment protocols.

Collaborations

Some of her notable coworkers include Robert A Beardsley and Dennis Patrick Riley, who contribute to her research and development efforts in the field.

Conclusion

Melissa Fath's contributions to cancer treatment through her innovative patents highlight her dedication to improving patient outcomes. Her work exemplifies the potential of combining therapies to enhance the effectiveness of cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…